Abstract | OBJECTIVE: METHODS: RESULTS: Our review revealed an overall success rate (microbiological cure + clinically improved) of 99.5%, with an overall success rate of 98.5% among burn patients, specifically. The overall success rate was 100% among patients in the three other diagnosis groups (cSSTIs, chronic wounds, and other infections). A success rate of 98% was noted among the subset of patients with wounds associated with bacteremia. CONCLUSIONS: Our study suggests that daptomycin is a safe and effective agent for the management of burn wound infections, although further study is warranted to confirm these results.
|
Authors | Bruce C Friedman, Luke Mendez-Vigo, Joan Wilson, Sara Yankelev |
Journal | Southern medical journal
(South Med J)
Vol. 103
Issue 8
Pg. 748-52
(Aug 2010)
ISSN: 1541-8243 [Electronic] United States |
PMID | 20622744
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Daptomycin
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents
(adverse effects, therapeutic use)
- Bacteremia
(drug therapy)
- Burn Units
(statistics & numerical data)
- Burns
(complications, drug therapy, microbiology)
- Daptomycin
(adverse effects, therapeutic use)
- Female
- Georgia
- Humans
- Male
- Middle Aged
- Retrospective Studies
- Treatment Outcome
- Wound Infection
(drug therapy, microbiology)
- Young Adult
|